CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-01 | Carey John F VP of Operations | Sale | −1,497 | $60.83 | $91K | 2,274 |
| 2022-12-01 | Carey John F VP of Operations | Sale | −1,403 | $61.70 | $87K | 871 |
| 2022-12-01 | Carey John F VP of Operations | Sale | −100 | $62.45 | $6K | 771 |
| 2022-12-01 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −3,000 | 6,273 | ||
| 2022-12-01 | Gordon Stephen Chief Financial Officer | Exercise or conversion | +10,000 | $16.14 | $161K | 15,714 |
| 2022-12-01 | Gordon Stephen Chief Financial Officer | Sale | −9,969 | $61.30 | $611K | 5,745 |
| 2022-12-01 | Gordon Stephen Chief Financial Officer | Sale | −31 | $62.15 | $2K | 5,714 |
| 2022-12-01 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 30,728 | ||
| 2022-12-01 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +11,051 | $2.21 | $24K | 11,051 |
| 2022-12-01 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −11,051 | 0 | ||
| 2022-11-23 | Lovell Stephanie Director | Exercise or conversion | +5,657 | $47.82 | $271K | 5,657 |
| 2022-11-23 | Lovell Stephanie Director | Sale | −5,657 | $59.50 | $337K | 0 |
| 2022-11-23 | Lovell Stephanie Director | Exercise or conversion · Stock Option (Right to Buy) | −5,657 | 8,543 | ||
| 2022-11-22 | Lovell Stephanie Director | Exercise or conversion | +3,800 | $47.82 | $182K | 3,800 |
| 2022-11-22 | Lovell Stephanie Director | Sale | −3,800 | $57.97 | $220K | 0 |
| 2022-11-22 | Lovell Stephanie Director | Exercise or conversion | +1,100 | $26.26 | $29K | 1,100 |
| 2022-11-22 | Lovell Stephanie Director | Sale | −1,100 | $58.04 | $64K | 0 |
| 2022-11-22 | Lovell Stephanie Director | Exercise or conversion · Stock Option (Right to Buy) | −3,800 | 14,200 | ||
| 2022-11-22 | Lovell Stephanie Director | Exercise or conversion · Stock Option (Right to Buy) | −1,100 | 1,150 | ||
| 2022-11-15 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +4,254 | $2.21 | $9K | 5,554 |
Page 33 of 38 · 744 trades